Anticancer drug targets: cell cycle and checkpoint control. - Wikidata - awgldk - TriplyDB

Anticancer drug targets: cell cycle and checkpoint control.

Anticancer drug targets: cell cycle and checkpoint control.

http://www.wikidata.org/entity/Q33801116

about

Identifying tumor cell growth inhibitors by combinatorial chemistry and zebrafish assays Substituted titanocenes induce caspase-dependent apoptosis in human epidermoid carcinoma cells in vitro and exhibit antitumour activity in vivo Wnt Signaling in Renal Cell Carcinoma An overview on the role of dietary phenolics for the treatment of cancers Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells Iron(III)-salophene: an organometallic compound with selective cytotoxic and anti-proliferative properties in platinum-resistant ovarian cancer cells Organometallic iron(III)-salophene exerts cytotoxic properties in neuroblastoma cells via MAPK activation and ROS generation Mitochondrial pathway mediates the antileukemic effects of Hemidesmus indicus, a promising botanical drug Isoalantolactone inhibits UM-SCC-10A cell growth via cell cycle arrest and apoptosis induction Sparstolonin B, a novel plant derived compound, arrests cell cycle and induces apoptosis in N-myc amplified and N-myc nonamplified neuroblastoma cells G2/M Cell Cycle Arrest and Tumor Selective Apoptosis of Acute Leukemia Cells by a Promising Benzophenone Thiosemicarbazone Compound Self-Driven Jamming in Growing Microbial Populations Persistence to anti-cancer treatments in the stationary to proliferating transition.The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma.Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC.Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs.Checkpoint genes in cancer.An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FOXO3a and p53 expression.Anti-proliferative of physcion 8-O-β-glucopyranoside isolated from Rumex japonicus Houtt. on A549 cell lines via inducing apoptosis and cell cycle arrest.Effect of immunostimulatory CpG-oligonucleotides in chronic lymphocytic leukemia B cells.Cell cyclins: triggering elements of cancer or not?Chemotherapeutic effect of calcidiol derivative B3CD in a neuroblastoma xenograft model.Design, synthesis, and biological evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine and its analogs as a novel class of anticancer agents.Cellular signalling pathways: new targets in leukaemia therapy.Adenovirus infection of primary malignant lymphoid cells.Antineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis.Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model.Exposure of human lung cancer cells to 8-chloro-adenosine induces G2/M arrest and mitotic catastrophe.BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability.Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells Abieslactone induces cell cycle arrest and apoptosis in human hepatocellular carcinomas through the mitochondrial pathway and the generation of reactive oxygen species DNA damage response and repair: insights into strategies for radiation sensitization of gliomas Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors Apoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cells Carrageenan delays cell cycle progression in human cancer cells in vitro demonstrated by FUCCI imaging.Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells

P2860

Q21092150-1346D020-5625-4FE1-9ED3-38A86891E358 Q24652956-986D5044-64D3-44B2-A1DB-01F201A0BCDA Q26744312-64282EE0-1CB6-4A93-BAD2-D7C2D3980990 Q28071894-B2F98734-51AC-434B-B7CC-AAD880C7A75E Q28366053-006D61E0-543F-4603-B891-452234AE61F6 Q28472804-DBAFC2AF-E4FA-4439-B7B6-645FFE6773A0 Q28477973-164DDE1F-776F-48C0-9630-0B384D54E9B7 Q28478861-AFA8E569-3AB7-4225-A97F-5AAC7E0994B6 Q28533893-0DDE3901-48D2-4F82-8A80-B0B7D8102BDA Q28538332-4D31F690-BD5A-4365-9C98-8B3E23E90FE2 Q28547905-335DFC61-1C1B-4F4B-905D-5564FD7C7E33 Q30811039-260EA74F-22CE-4D46-9C8C-2AF5BF7CB013 Q30834504-FA6A1865-87A8-4FBE-ABDC-E2A1A9E78E7D Q32186950-71A829E2-6E73-4FF9-AD3D-E65022B7E593 Q33290258-46BC610E-2A2B-4930-AE92-88D48762D863 Q33534491-138EC5D9-C159-4871-979F-76FB08CFEB74 Q33586833-E89D8A76-4726-4493-9A8A-3DDA9DB3247D Q33809305-C34B0CA0-EBCC-4F85-BD4E-8887C8FC57EE Q33939126-AABBCA85-2A9A-4305-9F61-FBE1729100E9 Q34235181-3359AA97-4A48-49D4-B8B9-90FE95082D72 Q34326755-C3E49372-623C-4440-BAC6-F415A5CC08DA Q34363051-13F4E969-22C4-4EF1-9B9F-D1E7B533B28B Q34431577-24B351DD-E4C9-428E-8EFC-B1BCB19B49CB Q34467866-9FD1C762-B438-44CE-8821-775D952141DB Q34505680-939FF97E-D285-4E65-BC43-62E36822CBC8 Q34520444-7AD7DDEC-2C6C-46E5-9DAA-C9A5DFCC048E Q34527660-D4960B75-19B2-4CBB-87D0-6B75C0031053 Q34573981-96297425-3DF0-4C9A-815E-CF1D55A4EAA8 Q34602854-3AC36D89-B226-4878-98C9-AF7A8A603FF5 Q34722614-AFB41A1C-45F8-49D7-ACE0-C9DA63FE0F19 Q34928853-A5B3D510-9940-4B67-91F2-B6E33D35E3C7 Q35022527-B2898C16-12F0-4B0C-96DF-FCEAD5A7721F Q35068068-20482A65-9FE2-4421-B1FF-BCB2A76FBB93 Q35515831-B050B23E-E1DA-4A93-A05E-482B97FE76CD Q35608458-EC290AAA-F869-49E3-8891-692B4C1739F9 Q35800291-F52785E2-6D9C-4572-AFD2-781A8B8A1875 Q36036927-E0A4EBD0-C51A-445D-BA37-19966AFB75C7 Q36094147-D0646F49-386B-4F7E-AF22-12DC65AEE56B Q36118431-16AB8325-874C-4F26-B505-9830F96FC5E1 Q36140567-C8A4D553-8A13-4702-96C7-C2BA96D9ACD7

P2860

Anticancer drug targets: cell cycle and checkpoint control.

http://www.wikidata.org/entity/Q33801116

description

1999 nî lūn-bûn

@nan

1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Anticancer drug targets: cell cycle and checkpoint control.

@ast

Anticancer drug targets: cell cycle and checkpoint control.

@en

type

label

Anticancer drug targets: cell cycle and checkpoint control.

@ast

Anticancer drug targets: cell cycle and checkpoint control.

@en

prefLabel

Anticancer drug targets: cell cycle and checkpoint control.

@ast

Anticancer drug targets: cell cycle and checkpoint control.

@en

P1433

Q33801116-4C8901D4-150E-4FB0-81C8-8B65CF66D1EC

P1476

Q33801116-5A88E69A-49DF-4B65-81FC-20144D729588

P2093

Q33801116-797D4AA8-79F9-413D-8E42-55478D1CDE5E

P2860

Q33801116-025197EB-6D9A-4002-B3CB-390DF5629569

Q33801116-0F7F10A4-75EA-4BCA-B141-D49F448D44AF

Q33801116-109D36CD-FC98-49A9-BF54-0B8F14AFBFC7

Q33801116-117FFB1D-2884-458D-9AEE-6E39A5A2EDBA

Q33801116-15F1CC2F-BD53-4355-9A42-D859533E90A7

Q33801116-1774129F-33FE-4CCC-98B6-68A4D0EC096B

Q33801116-3B9C5B72-E125-4009-B944-C3F78807D043

Q33801116-4B3DD79B-0483-4612-B4C7-D50DC0C3F18C

Q33801116-5B01BD06-8F96-4A56-A8F7-BBA034381F22

Q33801116-5BBF4543-1CA8-4B49-A92C-B7DEBD086571

P304

Q33801116-969ABB0F-0A12-4FD0-A06A-4E9CEE0CB797

P31

Q33801116-1BA87B9F-744D-4428-AB08-8AAE73E70BA0

P356

Q33801116-028AE811-A48A-4B92-90D2-D3A747BF12FE

P407

Q33801116-E4E216B7-99B1-4D4D-9F52-D86BB89AA841

P433

Q33801116-446325C3-C2BB-4808-AACB-36B6570D194C

P478

Q33801116-D768618A-781A-4C3F-BBF8-30B3420AB2F4

P50

Q33801116-2BF827AF-7122-4886-8F43-AFE77BD8ADD1

P577

Q33801116-E9721317-3077-423A-8F26-E52EEAFFC3CA

P698

Q33801116-E36E023C-8C5B-4A09-9055-299E57AA6E30

P932

Q33801116-2BB9D816-140D-435F-ABD2-CD30569D129D

P356

P1433

Journal of Clinical Investigation

P1476

Anticancer drug targets: cell cycle and checkpoint control

@en

P2093

Shapiro GI

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity

Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

CDK inhibitors: positive and negative regulators of G1-phase progression

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

Distinct roles for cyclin-dependent kinases in cell cycle control

Cell cycle control and cancer

P304

1645-1653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI9054

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey W. Harper

P577

1999-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10606615

http://www.w3.org/2001/XMLSchema#string

P932

409893

http://www.w3.org/2001/XMLSchema#string